Eisele; Karl-Heinz

Patent Applications and Registrations

Patent applications and USPTO patent grants for Eisele; Karl-Heinz.The latest application filed is for "cellular test systems for the determination of the biological activities of neurotoxin polypeptides".

Company Profile

3.14.18

Eisele; Karl-Heinz - Frankfurt am Main DE
Eisele; Karl-Heinz - Filderstadt DE

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Gangliosides for standardizing and increasing the sensitivity of cells to botulinum neurotoxins in in vitro test systems Grant 10,921,312 - Eisele February 16, 2	2021-02-16
Cellular test systems for the determination of the biological activities of neurotoxin polypeptides Grant 10,781,421 - Eisele , et al. Sept	2020-09-22
Methods for enhancing the specific uptake of botulinum neurotoxins into cells Grant 10,725,025 - Jatzke , et al.	2020-07-28
Methods for the determination of the biological activities of neurotoxin polypeptides Grant 10,634,683 - Eisele	2020-04-28
Cellular Test Systems For The Determination Of The Biological Activities Of Neurotoxin Polypeptides App 20190032009 - EISELE; Karl-Heinz ; et al.	2019-01-31
Cellular test systems for the determination of the biological activities of neurotoxin polypeptides Grant 10,125,350 - Eisele , et al. November 13, 2	2018-11-13
Methods For Enhancing The Specific Uptake Of Botulinum Neurotoxins Into Cells App 20180238861 - JATZKE; Claudia ; et al.	2018-08-23
Antibody that specifically binds partially processed or unprocessed neurotoxin polypeptides Grant 9,963,502 - Pfeil , et al. May 8, 2	2018-05-08
Methods For The Determination Of The Biological Activities Of Neurotoxin Polypeptides App 20180045733 - EISELE; Karl-Heinz	2018-02-15
Gangliosides For Standardizing And Increasing The Sensitivity Of Cells To Botulinum Neurotoxins In In Vitro Test Systems App 20170059558 - EISELE; Karl-Heinz ; et al.	2017-03-02
Means And Methods For Manufacturing Highly Pure Neurotoxin App 20160340417 - PFEIL; Michael ; et al.	2016-11-24
Means And Methods For Determination Of Botulinum Neurotoxin Biological Activity App 20160289731 - EISELE; Karl-Heinz ; et al.	2016-10-06
Means and methods for manufacturing highly pure neurotoxin Grant 9,447,175 - Pfeil , et al. September 20, 2	2016-09-20
Modified neurotoxins with poly-glycine and uses thereof Grant 9,314,514 - Eisele April 19, 2	2016-04-19
In vitro assay for quantifying clostridial neurotoxin activity Grant 9,310,386 - Wilk , et al. April 12, 2	2016-04-12
System for determining unprocessed and partially processed neurotoxin type A Grant 9,213,026 - Taylor , et al. December 15, 2	2015-12-15
Cellular Test Systems For The Determination Of The Biological Activities Of Neurotoxin Polypeptides App 20150267168 - Eisele; Karl-Heinz	2015-09-24
Means And Methods For Determining Neurotoxin Activity Based On A Modified Luciferase App 20150044709 - Eisele; Karl-Heinz	2015-02-12
System For Determining Unprocessed And Partially Processed Neurotoxin Type A App 20140349322 - TAYLOR; Harold Victor ; et al.	2014-11-27
Modified Neurotoxins With Poly-glycine And Uses Thereof App 20140308266 - Eisele; Karl-Heinz	2014-10-16
System for determining unprocessed and partially processed neurotoxin type A Grant 8,841,080 - Taylor , et al. September 23, 2	2014-09-23
Selective Manufacture Of Recombinant Neurotoxin Polypeptides App 20130158235 - Grein; Swen ; et al.	2013-06-20
In Vitro Assay For Quantifying Clostridial Neurotoxin Activity App 20130022992 - Wilk; Thomas ; et al.	2013-01-24
Assay For Quantifying Clostridial Neurotoxin App 20120282647 - Mander; Gerd J ; et al.	2012-11-08
System For Determining Unprocessed And Partially Processed Neurotoxin Type A App 20120214182 - Taylor; Harold Victor ; et al.	2012-08-23
Means And Methods For Manufacturing Highly Pure Neurotoxin App 20120004179 - Pfeil; Michael ; et al.	2012-01-05
Process for providing a temperature-stable muscle relaxant on the basis of the neurotoxic component of botulinum toxin App 20090010965 - Eisele; Karl-Heinz ; et al.	2009-01-08

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.